Citi raised the firm’s price target on Bausch + Lomb (BLCO) to $21 from $20 and keeps a Buy rating on the shares. The firm updated the company’s model post the Q4 report.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BLCO:
- Bausch + Lomb price target raised to $20 from $17 at Barclays
- Maintaining Sell: Structural Overhangs and Margin Shortfalls Overshadow Bausch + Lomb’s Growth Story
- Bausch + Lomb Signals Profitable Growth After Record Year
- Bausch + Lomb Lifts 2025 Revenue on Dry Eye and Vision Care Growth
- Bausch + Lomb sees FY26 revenue $5.375B-$5.475B, consensus $5.38B